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Agingater injury during ischemia (ISC) and reperfusion (REP) compared to the adult
heart. In the Fischer 344 (F344) rat, aging decreases oxidative phosphorylation and complex III activity
increasing the production of reactive oxygen species in interﬁbrillar mitochondria (IFM) located among the
myoﬁbrils. In the isolated, perfused 24 month old elderly F344 rat heart 25 min of stop–ﬂow ISC causes
additional damage to complex III, further decreasing the rate of oxidative phosphorylation. We did not
observe further progressive mitochondrial damage during REP. We next asked if ISC or REP increased
oxidative damage within mitochondria of the aged heart. Cardiolipin (CL) is a phospholipid unique to
mitochondria consisting predominantly of four linoleic acid residues (C18:2). Following ISC and REP in the
aged heart, there is a new CL species containing three oxygen atoms added to one linoleic residue. ISC alone
was sufﬁcient to generate this new oxidized molecular species of CL. Based upon oxidative damage to CL,
complex III activity, and oxidative phosphorylation, mitochondrial damage thus occurs in the aged heart
mainly during ISC, rather than during REP. Mitochondrial damage during ischemia sets the stage for
mitochondrial-driven cardiomyocyte injury during reperfusion in the aged heart.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionDespite timely and successful reperfusion elderly patients sustain
greater mortality and cardiac injury with acute myocardial infarction
[1]. The Fischer 344 rat model of aging (F344) was used to investigate
mechanisms of the enhanced susceptibility to myocardial damage.
Isolated, buffer-perfused hearts from 24 mo. F344 rats (aged) exhibit
decreased hemodynamic recovery and greater myocardial cell death
following 25 min of 37 °C global stop–ﬂow ischemia and 30 min
reperfusion compared to hearts from 6 mo. adult controls [2], pro-
viding an appropriate cardiac model for study. Other laboratories also
have observed enhanced cardiac damage in the aged Fischer 344 rat
heart [3–5] as well as age-related increases in other rat strains [6] and
other species [7,8]. Ischemic preconditioning, where antecedent
periods of brief ischemia limit injury from a subsequent longer period
of ischemia [5,9,10], is ineffective in the aged rat [5,11,12] and human
hearts [13,14]. Thus, additional understanding of the mechanisms that
underlie the age-enhanced susceptibility to ischemic damage are
needed in order to develop strategies to protect the elderly heart
during ischemia and reperfusion.logy, Case Western Reserve
leveland, OH 44106, USA. Tel.:
l).
ll rights reserved.Mitochondrial dysfunction contributes to aging in the heart by
increasing the production of reactive oxygen species (ROS) [15] and by
favoring the release of cytochrome c to activate cell death pathways
[16]. Mitochondrial defects predispose to an increase in cardiomyocyte
death that leads to age-related decreases in cardiomyocyte number
and an increase in areas of ﬁbrosis [17]. Cardiac mitochondria exist in
two functionally distinct populations within the myocyte. Subsarco-
lemmal mitochondria (SSM) are located underneath the plasma
membrane and interﬁbrillar mitochondria (IFM) are situated among
the myoﬁbrils [18]. The content of IFM is decreased in the aged heart
[19]. The rate of oxidative phosphorylation (OXPHOS) is decreased
in IFM from hearts in 24 mo aged F334 rats, whereas SSM remain
unaffected [19]. OXPHOS is tightly coupled in IFM from aged rats [19].
Dinitrophenol-uncoupled respiration is decreased, localizing the
defect to the electron transport chain (ETC) [19]. IFM exhibit a decrease
in OXPHOS with age using TMPD-ascorbate, an electron donor to
complex IV, as a substrate [19]. Complex IV enzyme activity decreases
with aging and is reversed by the addition of exogenous phospholipid
liposomes [19,20], localizing the defect to the lipid environment of the
inner mitochondrial membrane, rather than to the peptide subunits of
complex IV [19–21].
Aging decreases the maximally expressed activity of complex III
measured in detergent-solubilized mitochondria in IFM from aged
hearts, but SSM are unaffected [22]. Complex III catalyzes electron
transfer fromubiquinol to cytochrome c coupled to proton translocation
Fig. 1. Ischemia markedly decreases the maximal ADP-stimulated rate of oxidative phosphorylation in both subsarcolemmal (SSM) and interﬁbrillar (IFM) mitochondria obtained
from the 24 month old Fischer 344 rat heart. Reperfusion does not result in additional decreases in the rate of oxidative phosphorylation. Decreases are observed with glutamate
(A), duroquinol, DHQ (B), and TMPD-ascorbate (C) as substrates. The decrease in the rate of respiration is similar in the mitochondria isolated both following 25' ischemia and
following 25' ischemia plus 30' reperfusion. (Mean±SD; ⁎pb0.05; p=NS Ischemia vs. Ischemia–Reperfusion.)
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monomer contains three subunits, cytochrome b, cytochrome c1, and
the iron–sulfur protein (ISP) that participate in electron transfer
[23,24,26,27]. The content of subunit peptides is not altered by age
[22]. Functional studies using partial reactions within complex III lo-calized the aging defect to the ubiquinone oxidation site of cytochrome
b in complex III (Qo site) in IFMwhereas SSMwere unaffected [28]. The
agingdefect in theQo site of complex III in IFM increases ROSproduction
[28]. The net release of H2O2 was increased in IFM isolated from aged
Fischer 344 rathearts compared to adult controls,whereas SSM,without
Fig. 2. Ischemiamarkedly decreases complex III activity (decylubiquinone:cytochrome c
reductase) in both subsarcolemmal (SSM) and interﬁbrillar (IFM)mitochondria obtained
from the 24 month old Fischer 344 rat heart. Reperfusion does not result in additional
decreases in complex III activity. The decreases in the rate of respiration are similar in the
mitochondria isolated both following 25' ischemia and following 25' ischemia plus 30'
reperfusion. (Mean±SD; ⁎pb0.05; p=NS Ischemia vs. Ischemia–Reperfusion.)
Table 1
Cardiolipin content and composition in the adult and aged heart following ischemia and
reperfusion
SSM IFM
Adult Aged Adult Aged
Cardiolipin
(nmol/mg protein)
49±4 50±6 53±8 42±8
1496/1448
(total ion current ratio)
0.075±0.06 0.387±0.27⁎ 0.079±0.041 0.317±0.095⁎
Mean±SD.
⁎ pb0.05 vs. adult; adult–6 month F344; aged 24 month F344.
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[15].
Mitochondria sustain progressive damage during ischemia in adult
and aged hearts [29–37]. Twenty-ﬁve minutes of global ischemia
decreases the activity of complex III, the content of cytochrome c, and
respiration through complex IV [38]. In contrast to the selectivity of
the aging defect to IFM, ischemia damages both SSM and IFM to a
similar extent in 6 and 24 mo. Fischer 344 rats [38]. In IFM from the
aged heart, ischemic defects are superimposed upon the pre-existing
aging defects [38]. Ischemia decreased complex III activity in both SSM
and IFM in adult and aged hearts via a functional inactivation of the
iron–sulfur peptide [38]. The iron–sulfur peptide is central to electron
transfer within complex III [24], in line with the observed additional
decrease in complex III activity. Based upon studies in the adult heart
ischemic damage to complex III also favors an increase in the pro-
duction and net release of ROS from mitochondria [39].
Cytochrome c transfers electrons from complex III to complex IV.
Following 25 min ischemia, cytochrome c content decreases in SSM
and IFM in the adult and aged heart [38]. Cardiolipin, enriched in
oxidatively sensitive linoleic acyl groups [40], interacts with cyto-
chrome c via non-ionic [41–43] and electrostatic [44] mechanisms
to localize cytochrome c at the inner mitochondrial membrane [44].
A decrease in cardiolipin content or the oxidative modiﬁcation of
cardiolipin diminishes the afﬁnity of cytochrome c for the inner mem-
brane [41–43], delocalizing cytochrome c into the intermembrane
space [44,45], the ﬁrst step leading to cytochrome c loss from mito-
chondria [44]. Release of cytochrome c from mitochondria in turn
activates caspases and cell death programs [46]. An increase in the
frequency of apoptotic myocytes is observed following ischemia and
reperfusion in the aged heart [3,8].
Mitochondria are both targets and sources of damage during
ischemia and reperfusion [46–48]. Ischemia damages the electrontransport chain [33] and decreases the rate of OXPHOS [37,38]. The
aged heart sustains greater myocardial injury during ischemia and
reperfusion compared to the adult heart [2]. We asked if mitochondria
in the aged heart sustain damage mainly during ischemia or sustain
progressive injury during reperfusion. We next asked if the mitochon-
drial injury occurred at least in part as a result of oxidative damage.
Preservation of mitochondrial function is critical in order to diminish
myocardial injury during ischemia and reperfusion.
2. Methods
The Animal Care and Use Committees of the Louis Stokes Cleveland Department of
Veterans Affairs Medical Center and Case Western Reserve University approved the
protocol. Male Fisher 344 rats (adult: 6–8 months of age and aged: 24 months of age)
were anesthetized with pentobarbital sodium (100 mg/kg i.p.) and anti-coagulated
with heparin (1000 IU/kg i.p.). Hearts were excised and perfused retrograde via the
aorta with modiﬁed Krebs–Henseleit (K–H) buffer oxygenated with 95% O2/5% CO2, as
previously described [49]. Isolated hearts were perfused for 15 min followed by 25 min
global stop–ﬂow ischemia at 37 °C with or without 30 min of reperfusion. Cardiac
mitochondria were isolated using the procedure of Palmer [18] except that trypsin was
used as the protease [49,50]. Mitochondrial protein concentrationwas measured by the
Lowry method, using bovine serum album as a standard. Mitochondrial respirationwas
measured using a Clark-type oxygen electrode at 30 °C as previously described [37,51].
Maximally expressed complex III activity was measured by following the increase in
absorbance of reduced cytochrome c at 550 nm in mitochondria solubilized with 2%
sodium cholate in 25 mM KH2PO4, pH 7.4, using 100 µM decylubiquinol as the electron
donor [22]. The separation, quantiﬁcation, and characterization of cardiolipin was
performed as previously described [50,52]. Phospholipids were extracted from SSM and
IFM by the Folchmethodwith 50 µM butylated hydroxytoluene added as an antioxidant
[52], the phospholipid fraction isolated using silica gel chromatography [53], and
cardiolipin isolated from the phospholipid fraction using normal phase HPLC [52].
Cardiolipin was quantiﬁed by organic phosphate measurement [52] and composition
assessed by separation into component molecular species using reversed phase HPLC
followed by electrospray ionization/mass spectrometry as previously described using a
Finnegan LCQ-Deca (San Jose, CA, USA) in the negative ion mode [52]. Data-dependent
MS3 fragmentation analysis from reverse phase HPLC separationwas utilized to identify
and characterize individual cardiolipin molecular species. Data are expressed as the
mean±standard error of the mean (SEM). Differences among groups were compared by
two-tailed Student t-test. A difference of pb0.05 was considered signiﬁcant.
3. Results
3.1. Ischemia, not reperfusion, leads to mitochondrial damage in the aged
heart
We studied if damage to the ETC and OXPHOS occurred mainly
during ischemia or during reperfusion in aged hearts. Ischemia
markedly decreased the rate of state 3 and increased the rate of
state 4 respiration with glutamate as substrate compared to
mitochondria isolated from time control rat hearts (Fig. 1A). The
ADP/O ratio was not changed by ischemia (data not shown). There
were no differences in the rate of state 3, state 4, and 2 mM ADP-
stimulated respiration in SSM or IFM with glutamate as complex I
substrate following ischemia and reperfusion compared to ischemia
alone (Fig. 1A). Ischemia decreased the rate of oxidative phosphoryla-
tion using substrates that donate electrons to complex III (duroqui-
nol), and to complex IV via cytochrome c (TMPD-ascorbate) in both
SSM and IFM (Figs. 1B, C). Reperfusion failed to further reduce the rate
of oxidative phosphorylation in SSM and IFM in aged hearts (Figs. 1B,
Fig. 3. Electrospray ionization mass spectrometry of cardiolipin molecular species separated by reverse phase HPLC (see Methods). (A) Cardiolipin from IFM from an adult rat
following ischemia and reperfusion. Fragmentation pattern of the 1486 amu (K+-adduct of the 1448-intact cardiolipin) major molecular species demonstrating themass spectral “foot
print”: 869-glycerophosphatidic acid fragment; 607-phosphatidic acid; 415-lysophosphatidic acid; 279-linoleic acid. (B) Cardiolipin from IFM from an aged rat following ischemia
and reperfusion Fragmentation pattern of the new 1535 amu (K+-adduct of the 1496-intact cardiolipin) molecular species demonstrating the mass spectral “foot print”: 917-
glycerophosphatidic acid fragment; 655-phosphatidic acid; 453-lysophosphatidic acid; 327-oxidized linoleic acid. The collision-induced dissociation demonstrates that the +48
addition tracks through each fragment to the acyl group.
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remained unchanged (data not shown). Similar rates were observed
for uncoupled respiration, localizing the defect to the ETC (data not
shown). Reperfusion did not cause an additional decrease in oxidation
rate of duroquinol or TMPD-ascorbate, indicating that reperfusion did
not lead to additional damage to the distal electron transport chain.
Myocardial ischemia decreased complex III activity in both SSM
and IFM from aged hearts (Fig. 2). Reperfusion did not result in a
further decrease of complex III activity, providing additional evidence
that damage during ischemia was dominant (Fig. 2). This observation
focused our attention on speciﬁc molecular targets of ischemia-
induced mitochondrial damage in the aged heart.
3.2. Ischemia leads to oxidative modiﬁcation to cardiolipin in the aged,
but not adult heart
We asked if ischemia or reperfusion altered the content or
composition of cardiolipin in the adult or aged heart. Adult and aged
hearts underwent 25 min ischemia with or without 30 min reper-
fusion. The content of cardiolipin measured by phosphate was
unchanged in both adult and aged hearts following ischemia and
reperfusion (Table 1). The average recovery of cardiolipin in both
adult and aged hearts following ischemia and reperfusionwas 97±4%.
Analysis of cardiolipin molecular species was performed using re-
versed phase HPLC, followed by electrospray ionization mass spectro-
metry. As seen in Fig. 3A the predominant cardiolipin species in IFM
following 25 min of ischemia and 30 min of reperfusion in the adult
6 month heart has an m/z of 1448 (potassium salt m/z 1486) and
represents tetra-linoleic-cardiolipin. In the IFM from the 24 month
aged F344 rat heart after ischemia and reperfusion, the reversed phase
HPLC of the cardiolipin fraction revealed a new molecular species of
cardiolipin with a m/z 1496 (potassium salt m/z 1535) (Fig. 3B) with a
shortened retention time (data not shown). The mass of the new
molecular species (1496) was increased by 48 compared to the tetra-
linoleic cardiolipin species. The collision-induced dissociation spectra
in the MS2 andMS3 revealed that the +48mass was present in a single
acyl group of cardiolipin. This rapid modiﬁcation of cardiolipin by +48
most likely represents the addition of three oxygen atoms and the
earlier elution time is consistent with the increase in polarity with the
addition of the oxygen atoms. The relative increase in the fractional
content of the new oxidized species was estimated using the ratio of
the integrated peak areas of the 1496 species to the 1448 species
(Table 1). The content of the oxidized species increased at least three-
fold in the aged heart compared to the adult heart (Table 1). These
ﬁndings indicate markedly increased selective oxidation of cardiolipin
in the aged heart during ischemia or reperfusion. We next asked if
these changes were observed during ischemia. Neither the content
nor the composition of the molecular species of cardiolipin were
different following 25 min of ischemia compared to that observed
with ischemia/reperfusion (data not shown). Thus, substantial
oxidative modiﬁcation to cardiolipin occurs during ischemia in the
aged heart.
4. Discussion
The aged heart sustains increased injury during ischemia and
reperfusion. Mitochondria are key contributors to myocardial injury
during ischemia as well as during reperfusion. Ischemic damage is
superimposed upon pre-existing age-related defects in mitochondrial
metabolism. Based upon the study of cardiolipin, oxidative damage
to mitochondria occurs mainly during ischemia in the aged heart.
Thus, oxidative processes are likely contributors to the mitochondrial
damage that occurs during ischemia in the aged heart. Future work is
needed in order to evaluate if the ischemic damage to mitochondria
leads to myocyte injury and cell death during ischemia or during the
early reperfusion period.The evolution of oxidative damage during ischemia initially may
appear to pose a conundrum. The generation of a detectable burst of
ROS early in reperfusion is widely accepted [54–59]. It was originally
thought that during cardiac ischemia the oxygen content rapidly
decreases to complete anoxia. However, during the initial progression
of myocardial ischemia, oxygen remains available [60]. During si-
mulated ischemia in cardiomyocytes, under conditions of oxygen de-
pletion, the ROS generation actually increases [61,62]. In the setting of
low ﬂow ischemia, ROS production occurs continuously [58]. Even
during stop ﬂow ischemia in the isolated perfused heart, tissue oxy-
gen remains detectable by sensitive electron paramagnetic resonance
measurement at least during the initial 10 min of ischemia [60].
Consistent with the presence of oxygen during the evolution of
ischemic injury, ROS production monitored on line increases during
global ischemia in the intact heart [56,63]. Mitochondria are themajor
source for ROS production during ischemia [61,62,64]. Superoxide
production during simulated ischemia in cardiac myocytes [61,62] and
during stop–ﬂow ischemia in the isolated heart [63] is decreased by
blockade of electron transfer into complex III. Complex III, a dominant
site for the extramitochondrial release of ROS [65,66], is a likely site for
the production of ROS that are detected within the cardiomyocyte
during ischemia.
Cardiolipin, a phospholipid unique to mitochondria, is located in
the inner mitochondrial membrane in close proximity to the sites of
ROS production. Cardiolipin is highly enriched in oxidatively sensitive
linoleic acid (C18:2) groups susceptible to lipid peroxide formation
[67–70] and thus is a prime target of the ROS produced from the ETC
during ischemia. In vitro, ROS production from the ETC, especially
complex III [71], can deplete cardiolipin. In pathologic settings in-
cluding oxidative stress, during ischemia, cytochrome c alters its in-
teraction with cardiolipin resulting in a new tertiary structure of
cytochrome c [72,73], allowing ROS to react via the heme prosthetic
group of cytochrome c to peroxidize cardiolipin [74]. The role of the
cytochrome c–cardiolipin peroxidase in ischemia or reperfusion is
unknown. Potential mechanisms of cardiolipin peroxidation during
ischemia include heavy metal, most likely iron, catalyzed chain
propagation reactions to generate oxidized linoleic acid residues in
cardiolipin [67,70], potential formation of the cytochrome c–cardioli-
pin peroxidase with subsequent cardiolipin peroxidation, or other
as yet unknown mechanisms of mitochondrial-medicated peroxida-
tion of linoleic acid. The formation of +48 amu compounds resulting
from mitochondrial-mediated peroxidation of linoleic acid has been
described [75–77]. The formation of a speciﬁc +48 amu product, rather
than a mixture of products, suggests the presence of a speciﬁc peptide
or enzymatic mechanism of peroxidation, rather than a stochastic
chemical lipid peroxidation process. Oxidative damage to cardiolipin
was increased in both SSM and IFM in the aged heart. Oxidative
damage to cardiolipin, in turn, favors the delocalization and release of
cytochrome c from the inner membrane, predisposing to its release
frommitochondria and the activation of cell death programs [44]. The
presence of oxidative damage in both populations of mitochondria
suggests that age-induced defects localized to IFMmay not be the sole
mechanism of the enhanced oxidative damage observed during
ischemia in the aged heart.
We hypothesized that the distal electron transport chain, including
complex III (perhaps in concert with the cytochrome c-peroxidase),
contributes to the ischemic damage to the ETC. To test this hypothesis, the
ETC was reversibly blocked proximal to complex III using amobarbital
(AMO). AMO, a short-acting barbiturate, speciﬁcally inhibits complex I
[78] based on studies in isolated and in situ cardiac mitochondria [63].
AMO treatment (2.5 mM) of the adult F344 rat heart immediately before
25 min ischemia protects SSM and IFM against damage during ischemia,
with preserved OXPHOS andmarkedly decreased cytochrome c loss [49].
Protection of OXPHOS during ischemia allows a critical test of the con-
tribution of ischemic mitochondrial damage to myocardial injury dur-
ing reperfusion. Protection of mitochondria led to improved contractile
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smaller infarcts in the adult F344 rat measured following 30 min reper-
fusion [79]. The cardiac protection observed when the heart is reperfused
in the settingof preservedmitochondrial functionprovides support for the
working hypothesis that ischemic damage to mitochondria is a key
mechanism of myocardial injury during reperfusion in the adult heart.
Reversible blockade of electron transport immediately before
25 min ischemia in the aged heart attenuates ischemic damage to
OXPHOS, reduces cytochrome c release, and decreases ischemic da-
mage to complex III, even in IFM that contain the aging defect [80].
Ischemic mitochondrial damage, in turn, contributes to cardiac injury
in the aged heart. Reperfusion of the aged heart in the absence of
superimposed ischemic mitochondrial damage improves hemody-
namic recovery and lessens cardiomyocyte death as assessed by the
release of lactate dehydrogenase during reperfusion [80]. Integrated
respiration and complex III that were protected from ischemic injury
by blockade of electron transport did not sustain additional injury
during reperfusion [80], again supporting the notion that mitochon-
drial damage occurs mainly during ischemia, in line with the ﬁndings
of the current study in untreated hearts. Thus, the mitochondrial
damage that occurs during ischemia contributes to injury in the aged
heart during reperfusion.
In contrast to ischemic defects, the age-related defect in complex
III independently contributes to cardiac injury during ischemia and
reperfusion. We studied if an intervention that improved age-related
defects in OXPHOS before ischemia would decrease myocardial injury
during subsequent ischemia and reperfusion. Treatment of aged rats
with acetylcarnitine (AcCN) increased the maximal rate of OXPHOS in
IFM and restored complex III activity to rates observed in the adult
heart [81]. Adult and aged F344 rat hearts underwent 25 min ische-
mia and 30 min reperfusion. In the aged heart, AcCN improved the
recovery of left ventricular developed pressure and decreased the
extent of myocardial cell death as measured by lactate dehydrogenase
release during reperfusion [81]. In contrast, in the adult heart, con-
tractile recovery and lactate dehydrogenase release during reperfu-
sion was unchanged by treatment. These observations support the
contribution of age-related defects to the increased damage obser-
ved following ischemia and reperfusion. Thus, pretreatment of aging
defects rendered the aged heart more resistant to ischemic injury
[81,82].
Restoration of OXPHOS and the complex III phenotype in the aged
heart decreases cardiac injury during ischemia and reperfusion.
Limitation of electron ﬂow into complex III during ischemia blunts
mitochondrial damage and decreases myocardial injury in the adult
heart. Thus, modulation of the ETC can attenuate cardiac injury during
ischemia and reperfusion. Although the concept that disrupting
effective oxidative metabolism to protect the heart initially appears
counterintuitive, blockade of electron transport decreases the produc-
tion and release of ROS from mitochondria and preserves mitochon-
drial integrity, leading to the retention of cytochrome c. Modulation of
mitochondrial metabolism by therapeutic intervention [81,82] is a key
potential mechanism of cardiac protection during ischemia and
reperfusion for both the adult and aged heart. However, this
conceptual approach, though intriguing, requires intervention before
and during ischemia, which limits application in many settings of
cardiac ischemia. The exciting option to utilize pretreatment of age-
related defects in a preemptive fashion to decrease ischemia–reper-
fusion cardiac injury represents a second novel cardioprotective
strategy for the aged heart. This approach treats aging defects to
inoculate the high-risk aged heart against injury before ischemia
occurs. Additional work is needed to evaluate if pretreatment to
reverse age-related defects also impacts on ischemic mitochondrial
damage. In a similar fashion, it will be important to determine if the
improvement in age-related defects in complex III attenuates the age-
enhanced production of oxidized cardiolipin during ischemia in the
elderly heart. An improved understanding of the contributions of agingdefects in relationship to ischemic defects in OXPHOS is of major
signiﬁcance in reducing cardiac injury in the elderly heart.
Ischemia damages the ETC in the aged heart, setting the stage for
cardiac injury during reperfusion. Reperfusion of the myocardium in
the setting of preserved OXPHOS decreases ROS production and
reduces infarct size, underscoring the role of ischemic ETC damage in
the genesis of cardiac injury. The ability to prevent ischemic damage
via reversible blockade of electron transport in the aged heart
provides the ﬁrst experimental approach to directly assess the
responses of mitochondria that have been damaged by ischemia
compared to mitochondria exposed to in situ ischemia but are devoid
of injury. Future studies of the responses of the two mitochondrial
phenotypes to the conditions of reperfusion should advance our
understanding of the mechanisms whereby ischemic damage to the
ETC is translated into mitochondrial-driven cardiomyocyte injury
during early reperfusion in the aged heart. We hypothesize that the
heart in human beings might be protected during reperfusion from
the deleterious consequences of resumption of aerobic metabolism by
ischemia-damaged mitochondria by modulating the respiratory
function of the damaged mitochondria during reperfusion.
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